Showing results (111-120 of 815) with videos related to
Sort By:
Pageof 82
Current Computer-Aided Drug Design|April 5, 2023
The Possibility of Polygonum cuspidatum against Osteoarthritis based on Network PharmacologyChengyin Liu, Lingyun Yu, Yixin Jiang, et al.Current Computer-Aided Drug Design|August 5, 2020
Identification of Antimycobacterial Agent Using In Silico Virtual Screening, ADME Prediction, Docking, and Molecular Dynamics Simulations ApproachSwayansiddha Tripathy, Susanta Kumar Sahu, Mohammed Afzal Azam, et al.Current Computer-Aided Drug Design|August 21, 2020
An Integrative Informatics Approach to Explain the Mechanism of Action of N1-(Anthraquinon-2-yl) Amidrazones as BCR/ABL InhibitorsDima A Sabbah, Rima Hajjo, Kamal Sweidan, et al.Current Computer-Aided Drug Design|June 30, 2020
Identification of Potential Inhibitors Against the TGF-β/BMPs-Activin Receptor- like Kinase 1 Signal PathwayMiao-Miao Wu, Mei-Lin Liu, Jing Zhou, et al.Current Computer-Aided Drug Design|June 30, 2020
Application of Molecular Docking for the Development of Improved HIV-1 Reverse Transcriptase InhibitorsArash Soltani, Seyed Isaac Hashemy, Farnaz Zahedi Avval, et al.Current Computer-Aided Drug Design|March 11, 2015
Structural characterization of Bacillus subtilis membrane protein Bmr: an in silico approachAmit Nargotra, Rukmankesh, Shakir Ali, et al.Current Computer-Aided Drug Design|March 11, 2015
QSAR models for the reactivation of sarin inhibited acetylcholinesterase by quaternary pyridinium oximes based on Monte Carlo methodAleksandar M Veselinović, Jovana B Veselinović, Andrey A Toropov, et al.Current Computer-Aided Drug Design|April 28, 2023
Development of Potential Inhibitors for Human T-lymphotropic Virus Type I Integrase Enzyme: A Molecular Modeling ApproachMohammad Jalili-Nik, Arash Soltani, Seyed Isaac Hashemy, et al.Current Computer-Aided Drug Design|June 28, 2012
An integrated drug development approach applying topological descriptorsAlan Talevi, Carolina L Bellera, Mauricio Di Ianni, et al.Current Computer-Aided Drug Design|June 28, 2012
Modeling anti-HIV compounds: the role of analogue-based approachesHemant Kumar Srivastava, Mohammed H Bohari, G Narahari SastryPageof 82